Detalles de la búsqueda
1.
The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Breast Cancer Res Treat
; 203(2): 339-349, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37878148
2.
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.
Breast Cancer Res Treat
; 205(2): 287-302, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381274
3.
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.
Breast Cancer Res Treat
; 192(2): 331-342, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025003
4.
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era.
Br J Cancer
; 124(2): 399-406, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33046804
5.
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial.
Breast Cancer Res Treat
; 185(3): 741-758, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179154
6.
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
Breast Cancer Res Treat
; 181(1): 77-86, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236826
7.
An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry.
Acta Oncol
; 59(9): 1123-1130, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32544366
8.
Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry.
Qual Life Res
; 29(12): 3363-3374, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816222
9.
Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 19(12): 1630-1640, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30413379
10.
Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.
Oncology
; 93(5): 323-328, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28848182
11.
Decision aids for second-line palliative chemotherapy: a randomised phase II multicentre trial.
BMC Med Inform Decis Mak
; 17(1): 130, 2017 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28859646
12.
Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium.
Oncologist
; 21(5): 555-62, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27009939
13.
Does long-term survival exist in pancreatic adenocarcinoma?
Acta Oncol
; 55(3): 259-64, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26559995
14.
Age-related systemic treatment and survival of patients with metachronous metastases from colorectal cancer.
Acta Oncol
; 55(12): 1443-1449, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27585122
15.
Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences.
J Cancer Educ
; 31(3): 443-8, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25985960
16.
Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium.
Oncologist
; 20(8): 856-63, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099745
17.
Expected survival with and without second-line palliative chemotherapy: who wants to know?
Health Expect
; 18(6): 2903-14, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25302963
18.
Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.
Clin Breast Cancer
; 24(2): 103-111, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38007349
19.
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.
Breast Cancer Res Treat
; 141(3): 507-14, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24104881
20.
Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling.
Cancers (Basel)
; 15(17)2023 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686693